IL42365A0 - Anti-inflammatory topical gel compositions - Google Patents

Anti-inflammatory topical gel compositions

Info

Publication number
IL42365A0
IL42365A0 IL42365A IL4236573A IL42365A0 IL 42365 A0 IL42365 A0 IL 42365A0 IL 42365 A IL42365 A IL 42365A IL 4236573 A IL4236573 A IL 4236573A IL 42365 A0 IL42365 A0 IL 42365A0
Authority
IL
Israel
Prior art keywords
gel compositions
topical gel
inflammatory topical
inflammatory
compositions
Prior art date
Application number
IL42365A
Other versions
IL42365A (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL42365A0 publication Critical patent/IL42365A0/en
Publication of IL42365A publication Critical patent/IL42365A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/76Nitrogen atoms to which a second hetero atom is attached
    • C07D213/77Hydrazine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL42365A 1972-06-09 1973-05-28 Anti-inflammatory topical composition containing 2-(4-pyridyl-6,16alpha-dimethyl-11beta,17alpha,21-trihydroxypregna-4,6-dieno(3,2-c)-pyrazol-20-one IL42365A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US26118672A 1972-06-09 1972-06-09
US26774372A 1972-06-30 1972-06-30

Publications (2)

Publication Number Publication Date
IL42365A0 true IL42365A0 (en) 1973-07-30
IL42365A IL42365A (en) 1977-04-29

Family

ID=26948452

Family Applications (1)

Application Number Title Priority Date Filing Date
IL42365A IL42365A (en) 1972-06-09 1973-05-28 Anti-inflammatory topical composition containing 2-(4-pyridyl-6,16alpha-dimethyl-11beta,17alpha,21-trihydroxypregna-4,6-dieno(3,2-c)-pyrazol-20-one

Country Status (8)

Country Link
CA (1) CA1014856A (en)
DE (1) DE2329130A1 (en)
FR (1) FR2187340B1 (en)
GB (1) GB1397893A (en)
IE (1) IE37718B1 (en)
IL (1) IL42365A (en)
NL (1) NL7307072A (en)
PH (1) PH10968A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3376957D1 (en) * 1982-06-24 1988-07-14 Robert Alan Smith Pharmaceutical gel composition
DE69029804T2 (en) 1989-06-07 1997-09-04 Gail S Bazzano VEHICLE WITH SLOW RELEASE TO REDUCE SKIN IRRITATION OF TOPICAL AGENTS CONTAINING RETINOIDS

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135267A (en) * 1971-02-25
BE786884A (en) * 1971-07-30 1973-01-29 Merck & Co Inc STERANIC PYRAZOLE AND PROCESS

Also Published As

Publication number Publication date
GB1397893A (en) 1975-06-18
NL7307072A (en) 1973-12-11
FR2187340A1 (en) 1974-01-18
FR2187340B1 (en) 1976-10-22
DE2329130A1 (en) 1973-12-20
IE37718B1 (en) 1977-09-28
PH10968A (en) 1977-10-18
AU5625573A (en) 1974-12-05
IL42365A (en) 1977-04-29
CA1014856A (en) 1977-08-02
IE37718L (en) 1973-12-09

Similar Documents

Publication Publication Date Title
CA1017672A (en) Dermatological compositions
AU483797B2 (en) Dermatological compositions
CA1019679A (en) Mild shampoo compositions
CA1020464A (en) Shampoo compositions
MY8000032A (en) Topical compositions
AU469815B2 (en) Anti-inflammatory compositions
ZA732269B (en) Dermatological compositions
ZA728988B (en) Novel anti-inflammatory agents
CA920609A (en) Anti-inflammatory agents
AU469389B2 (en) Polyvinylchloride compositions
IL42365A0 (en) Anti-inflammatory topical gel compositions
BE795744A (en) FLAMMATION-DELAYING COMPOSITIONS
AU474642B2 (en) Polyvinylchloride compositions
CA1001072A (en) Compositions zootechniques
AU444636B2 (en) Soil-binding compositions
AU471785B2 (en) Therapeutic compositions
CA1001920A (en) Compositions extinctrices
ZA732597B (en) Anti-inflammatory topical gel
CA894207A (en) Therapeutic compositions for topical application
AU485607B2 (en) Compositions
ZA731164B (en) Novel steroidal composition having topical anti-inflammatory properties
CA914577A (en) Topical anti-inflammatory composition containing (indazole-3-yl)-oxyalkanoic acids
AU470518B2 (en) Dermatological compositions
CA897064A (en) Therapeutic compositions
CA907519A (en) Therapeutic compositions